The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma

Abstract Novel promising strategies for combination with sorafenib are urgently needed to enhance its clinical benefit and overcome toxicity in hepatocellular carcinoma (HCC). the molecular and immunomodulatory antitumor effects of sorafenib alone and in combination with the new immunotherapeutic ag...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuchao He, Linlin Zhan, Jian Shi, Manyu Xiao, Ran Zuo, Chengmeng Wang, Zhiyong Liu, Wenchen Gong, Liwei Chen, Yi Luo, Shaojun Zhang, Youwei Wang, Lu Chen, Hua Guo
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2023-06-01
Col·lecció:	Advanced Science
Matèries:	hepatocellular carcinoma immune microenvironment R848 sorafenib vascular normalization
Accés en línia:	https://doi.org/10.1002/advs.202207650
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!